Radioactive iodine (RAI) therapy is preferred in the treatment of toxic autonomous adenomas because of its effectiveness, noninvasiveness, and low costs (1) . Among patients with toxic adenomas, radioiodine therapy not only ameliorates hyperthyroidism but also reduces the size of the adenomas (2) .Objective: 
noninvasiveness, and low costs (1) . Among patients with toxic adenomas, radioiodine therapy not only ameliorates hyperthyroidism but also reduces the size of the adenomas (2) .Objective: The aim of this retrospective study is to detect the long term 
INTRODUCTION:
Solitary hyper functioning thyroid adenomas are lesions tumors characterized by their capacity to grow and produce thyroxin (T4) and triiodothyronine (T3) autonomously, i.e. in the absence of TSH stimulation (3) . Toxic adenoma cause autonomous, unregulated synthesis of thyroid hormone. In some cases, the cause is a mutation in the thyrotropin receptor gene, which results in constitutive activation. In rare cases, toxic adenoma may have spontaneous infarction of a toxic adenoma (4) .The rate of development of toxic symptoms in patients with hyper functioning adenomas who are euthyroid is seen in 4% per year and depends on the size of the adenoma, iodine intake and age of the patient (3) .Toxic autonomous nodules are rarely malignant and they require radionuclide scan for assessment (5) .Serum TSH measurement has the highest sensitivity and specificity in the evaluation of suspected toxicity. However, diagnostic accuracy improves when both a serum TSH and free thyroxin (FT4) are assessed at the time of the initial evaluation which have an inverse log-linear relationship (suppressed TSH with elevated FT4 level) therefore, small changes in free T4 result in large changes in serum TSH concentrations (6) .Thyroid scintigraphy (with The diagnosis of toxic adenoma is established in the presence of a "hot" thyroid nodule along with complete or partial suppression of the remaining thyroid tissue on scintigraphy, in combination with biochemical evidence of hyperthyroidism (7) .
Thyroid ultrasound (US) is the most sensitive method to detect thyroid nodules which may be malignant and influence choice of the treatment (8) .
It
does not generally contribute to the differential diagnosis of hyperthyroidism, however when RAI is contraindicated, such as during pregnancy or breast feeding, (US) showing increased color Doppler flow which may be helpful in confirming a diagnosis of thyroid hyperactivity (9) . Radioactive iodine (RAI) therapy is preferred in the treatment of toxic autonomous adenomas because of its effectiveness, noninvasiveness, and low cost (1) . Among patients with toxic adenomas, radioiodine therapy not only ameliorates hyperthyroidism but also reduces the size of the adenomas (2) .A variety of methods have been used to select the amount of administered activity. These include the calculated dose aiming to deliver a specific dose to the thyroid based on gland size which was determined by calculation of thyroid volume using radionuclide scanning or ultrasound, maximal uptake and effective half-life of iodine of the thyroid (10) .Empiric fixed doses of 131RAI are frequently determined by the quantity that would not require hospitalization of the patient on the basis of local and national regulations. The doses range from 370 MBq to 1.1 GBq (10-30 mCi) (10) . (RAI) treatment avoids surgery but requires radiation safety education and planning (5).Follow-up examination at 6 months intervals is advised for patients after the completion of radioactive iodine therapy. These check-ups should be continued until patients return to their euthyroid state and their condition stabilizes (11) .Hypothyroidism is rare complication following treatment of autonomous adenoma with radionuclide in view of intake of radionuclide by nodule, while suppressed thyroid tissue will recover with return of gland to euthyroid state (12) .The main argument against the use of 131 I versus the surgical approach in the treatment of toxic adenoma is rare possible coexistence of thyroid cancer (13) .
PATIENTS AND METHODS:
Case The current study included 60 patients with autonomous toxic adenoma, 50 patients (83.3%) were females and 10 patients (13.7%)
were males similar date was reported by.
Ioanna,et al (7) . They treated 126 patients with hyperthyroidism due to toxic adenoma, (110 females, 16 males) (7) .
The mean age of our patients was 52.7 years,
Harach et al (15) showed similar date of nearly the same mean age.
Our study showed that all patients with autonomous toxic adenoma had suppressed base line TSH, whereas Chami,et al (16) in a study on 368 patients with toxic adenoma stated that serum TSH is an effective tool in the diagnosis of toxic adenoma as some patients may have euthyroid state (16) .
In the present study, complete treatment rate of (20) .
Post treatment hypothyroidism in our patients did not correlate with the adenoma size, patient's age or 131-I dose. None of our patients developed any malignancy during the follow-up period, in agreement with reports of no increased risk for thyroid malignancy(21), other cancers (22) , and leukemia (23) post 131I treatment with very low risk (»1.5 %), although rates as high as 2.5-5.4% have been reported in some studies (23, 24) .
In the contrary, surgery in the form of lobectomy can be another modality for treatment of toxic adenoma, offers only partial protection due to the well documented multifocality, especially in papillary carcinoma where microscopic foci of cancer are detected in the opposite lobe in 30-82% of patients (25) .
However, no reported patients performed surgery in the present study.
In conclusion, our findings suggest that 
